Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Aquestive Therapeutics, Inc. AQST

Full chart Compare
Set alert

Price alert · AQST

All alert types
3.59 USD -0.02 (-0.69%)

Nov 9, 2026, 2:05 PM EST

3.37 Day range 3.67
2.93 52-week range 6.74
YTD
-44.50%
1 year
-40.65%

Financial health

Altman Z-Score

-4.87 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -8.5×
FY 2016: -41.2×FY 2017: -35.7×FY 2018: -2.1×FY 2019: -2.0×FY 2020: -3.2×FY 2021: -2.1×FY 2022: -0.8×FY 2023: -15.5×FY 2024: -7.0×FY 2025: -8.5×
FY 2016 5y median -7.0× FY 2025
P/S 17.7×
FY 2016: 7.6×FY 2017: 4.8×FY 2018: 1.9×FY 2019: 2.8×FY 2020: 3.9×FY 2021: 2.9×FY 2022: 0.9×FY 2023: 2.4×FY 2024: 5.4×FY 2025: 17.7×
FY 2016 5y median 2.9× FY 2025
P/B -23.4×
FY 2016: -22.4×FY 2017: -12.1×FY 2018: 13.0×FY 2019: -24.1×FY 2020: -3.7×FY 2021: -1.8×FY 2022: -0.4×FY 2023: -1.2×FY 2024: -5.1×FY 2025: -23.4×
FY 2016 5y median -1.8× FY 2025
P/FCF -14.9×
FY 2016: -43.0×FY 2017: 85.5×FY 2018: -8.8×FY 2019: -2.4×FY 2020: -3.9×FY 2021: -4.4×FY 2022: -3.6×FY 2023: -16.8×FY 2024: -8.6×FY 2025: -14.9×
FY 2016 5y median -8.6× FY 2025
EV/EBITDA -12.1×
FY 2016: 144×FY 2017: 136×FY 2018: -2.3×FY 2019: -2.9×FY 2020: -4.8×FY 2021: -3.9×FY 2022: -1.9×FY 2023: 113×FY 2024: -10.3×FY 2025: -12.1×
FY 2016 5y median -3.9× FY 2025
EV/Sales 17.9×
FY 2016: 8.2×FY 2017: 5.2×FY 2018: 1.7×FY 2019: 3.0×FY 2020: 4.1×FY 2021: 3.5×FY 2022: 1.6×FY 2023: 2.6×FY 2024: 4.8×FY 2025: 17.9×
FY 2016 5y median 3.5× FY 2025
FCF Yield -6.7%
FY 2016: -2.3%FY 2017: 1.2%FY 2018: -11.3%FY 2019: -41.2%FY 2020: -25.5%FY 2021: -22.9%FY 2022: -28.0%FY 2023: -6.0%FY 2024: -11.6%FY 2025: -6.7%
FY 2016 5y median -11.6% FY 2025

Profitability

Gross Margin 61.5%
FY 2016: 68.4%FY 2017: 70.4%FY 2018: 68.9%FY 2019: 61.3%FY 2020: 71.7%FY 2021: 70.5%FY 2022: 59.3%FY 2023: 58.8%FY 2024: 69.0%FY 2025: 61.5%
FY 2016 5y median 61.5% FY 2025
Operating Margin -156.4%
FY 2016: -1.6%FY 2017: -0.2%FY 2018: -72.6%FY 2019: -100.1%FY 2020: -93.6%FY 2021: -68.2%FY 2022: -88.2%FY 2023: -29.9%FY 2024: -53.5%FY 2025: -156.4%
FY 2016 5y median -68.2% FY 2025
Net Margin -188.1%
FY 2016: -18.5%FY 2017: -13.4%FY 2018: -91.0%FY 2019: -125.9%FY 2020: -121.7%FY 2021: -138.8%FY 2022: -114.1%FY 2023: -15.6%FY 2024: -76.7%FY 2025: -188.1%
FY 2016 5y median -114.1% FY 2025
ROE 248.9%
FY 2016: 54.6%FY 2017: 33.8%FY 2018: -608.9%FY 2019: 1082.1%FY 2020: 115.0%FY 2021: 85.9%FY 2022: 45.9%FY 2023: 7.4%FY 2024: 73.4%FY 2025: 248.9%
FY 2016 5y median 73.4% FY 2025
ROIC -56.0%
FY 2016: -3.0%FY 2017: -0.4%FY 2018: -83.6%FY 2019: -87.9%FY 2020: -95.1%FY 2021: -80.7%FY 2022: -115.3%FY 2023: -38.2%FY 2024: -37.0%FY 2025: -56.0%
FY 2016 5y median -56.0% FY 2025
ROA -52.2%
FY 2016: -24.4%FY 2017: -20.7%FY 2018: -70.7%FY 2019: -84.4%FY 2020: -88.7%FY 2021: -113.8%FY 2022: -95.3%FY 2023: -13.7%FY 2024: -43.5%FY 2025: -52.2%
FY 2016 5y median -52.2% FY 2025

Growth (YoY)

Revenue -22.6%
FY 2016: 0.0%FY 2017: 29.2%FY 2018: 0.8%FY 2019: -22.0%FY 2020: -12.8%FY 2021: 10.9%FY 2022: -6.2%FY 2023: 6.1%FY 2024: 13.8%FY 2025: -22.6%
FY 2016 FY 2025
Operating Income -126.4%
FY 2016: 0.0%FY 2017: 86.7%FY 2018: -43204.4%FY 2019: -7.6%FY 2020: 18.6%FY 2021: 19.1%FY 2022: -21.3%FY 2023: 64.1%FY 2024: -103.8%FY 2025: -126.4%
FY 2016 FY 2025
EPS (diluted) -49.0%
FY 2016: 0.0%FY 2017: -15.4%FY 2018: -557.8%FY 2019: 3.0%FY 2020: 42.2%FY 2021: -11.4%FY 2022: 39.5%FY 2023: 88.4%FY 2024: -292.3%FY 2025: -49.0%
FY 2016 FY 2025
Free Cash Flow -47.5%
FY 2016: 0.0%FY 2017: 141.0%FY 2018: -494.4%FY 2019: -310.9%FY 2020: 24.5%FY 2021: 26.3%FY 2022: 63.7%FY 2023: 40.1%FY 2024: -387.0%FY 2025: -47.5%
FY 2016 FY 2025

Financial Health

Current Ratio 3.1×
FY 2016: 2.2×FY 2017: 1.8×FY 2018: 2.3×FY 2019: 3.7×FY 2020: 2.1×FY 2021: 2.2×FY 2022: 1.0×FY 2023: 2.2×FY 2024: 4.7×FY 2025: 3.1×
FY 2016 5y median 2.2× FY 2025
Quick Ratio 3.0×
FY 2016: 1.9×FY 2017: 1.6×FY 2018: 2.1×FY 2019: 3.5×FY 2020: 2.0×FY 2021: 2.0×FY 2022: 0.9×FY 2023: 1.9×FY 2024: 4.4×FY 2025: 3.0×
FY 2016 5y median 2.0× FY 2025
Debt / Equity -3.9×
FY 2016: -2.2×FY 2017: -1.7×FY 2018: 4.7×FY 2019: -9.9×FY 2020: -0.8×FY 2021: -0.7×FY 2022: -0.5×FY 2023: -0.3×FY 2024: -0.6×FY 2025: -3.9×
FY 2016 5y median -0.6× FY 2025
Net Debt / EBITDA -0.2×
FY 2016: 10.0×FY 2017: 11.0×FY 2018: 0.3×FY 2019: -0.2×FY 2020: -0.2×FY 2021: -0.6×FY 2022: -0.8×FY 2023: 8.0×FY 2024: 1.3×FY 2025: -0.2×
FY 2016 5y median -0.2× FY 2025
Interest Coverage -4.1×
FY 2016: -0.1×FY 2017: -0.0×FY 2018: -6.3×FY 2019: -5.7×FY 2020: -3.3×FY 2021: -1.5×FY 2022: -3.4×FY 2023: -2.0×FY 2024: -1.8×FY 2025: -4.1×
FY 2016 5y median -2.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31